A visionary leader and accomplished expert in medical device technology, with a passion for advancing healthcare through innovation in cardiology and heart failure management. With a career spanning over more than two decades, Peter has made significant technology and business contributions to the fields of implantable therapeutic medical devices and non-invasive cardiac monitoring and diagnostics. Peter’s journey in the medical technology industry began with a deep-seated desire to make a meaningful impact on patient outcomes and quality of life. Throughout his career, he has held executive leadership roles in renowned medical device companies like BIOTRIONIK as well as early-stage companies like Inovise Medical, where under his leadership the company emerged as an international trailblazer in the development of non-invasive solutions for early detection and management of cardiac conditions. Thereby gaining invaluable business start-up and growth experience, and deep domain knowledge in business development, operations, development, clinical studies, and early commercialization. Currently serving as the CEO of VisCardia, Peter oversees the strategic direction and operations of the company, driving its mission to address a significant gap in therapeutic options for heart failure patients who remain symptomatic despite being on guideline directed medical treatment, a $10Bn market opportunity levering the company’s breakthrough technology with a clear line of sight towards commercialization.